Skip to Content
Søk Menu

Share clinical knowledge & best practice to improve health & patient care

BestPractice Nordic arbeider for å forbedre folkehelsen og pasientbehandlingen gjennom dialog og formidling av best practice mellom leger og helsepersonell.

Få tilgang

Siste artikler fra alle specialerne

Azacitidine was generally well tolerated in patients ≥ 75 years of age in QUAZAR AML-001

/ BestPractice Nordic
AMLEHA21

CAR-T cell therapy provides early and deep response in multiple myeloma patients

/ BestPractice Nordic
MyelomatoseEHA21

mutNPM1 status is a prognostic and an independent predictive marker for improved survival with azacitidine

/ BestPractice Nordic
AMLEHA21

Specialeoversikt

Siste magasin fra Best Practice Nordic

Onkologi / Hematologi • Nr. 4 • 2021

  • Nytt fra SABCS
  • Lungekreft
  • Nytt fra ASH
  • Myelomatose
Få tilgang

Få tilsendt tidsskriftet BestPractice Nordic gratis

Registrer deg eller oppdater profilen din her

Registrer deg

Gå ikke glipp av de siste nyhetene fra ditt spesialområde

Registrer deg og få nye artikler, MEDtalks, MEDcast og tidsskrifter direkte til din innboks

Få adgang

MEDtalk: Spesialister presenterer den nyeste forskningen innen lungekreft, diabetes, osteoporose og mange flere emner

European white paper: oropharyngeal dysphagia in head and neck cancer

  • / Jesper Grau Eriksen

Flere episoder

Treatment of itch – Now and in the future

/ Dermatologi / Brian Kim

A novel prognostic marker associated with superior patient survival in soft tissue sarcoma

/ Onkologi / Hematologi / Monika Ehnman

Langtidsvirkende prævention til kvinder under 20 år er gratis i Norge

/ Sykepleierne / Trine Aarvold

EHA-ESMO Clinical Practice Guidelines for Multiple Myeloma

/ Onkologi / Hematologi / Fredrik Schjesvold

Potential to become the best treatment for multiple myeloma in history

/ Onkologi / Hematologi / Thierry Facon

COVID-19 Perspectives

Sign up to get latest evidence, management guidelines, healthcare perspectives and commentaries about COVID-19

Get COVID-19 Perspectives

Annonsør?

Få en oversikt over sponsor- og annonseringsmuligheter i BestPractice Nordic

Se mer her

Siste innholdet fra alle specialerne

Differences in HbA1c do not explain cardiovascular benefits in the treatment of type 2 diabetes

/ Odd Erik Johansen
Type 2-diabetes Play the Video

New bispecific antibody with promising efficacy and safety profil for patients with relapsed/refractory Multiple Myeloma

/ Amrita Y. Krishnan
EHA21 Play the Video

First-in-human study of teclistamab for relapsed/refractory Multiple Myeloma

/ Niels van de Donk
EHA21 Play the Video

Early responses for BCMA-directed CAR-T cell therapy in progressive MM after 1-3 prior lines of therapy

/ Mounzer Agha
EHA21 Play the Video
Christian Pollock Fjellstad

Rheumatoid arthritis – treatment in a patients perspective

/ Christian Pollock Fjellstad
EULARRevmatoid artritt Play the Video

The first-in-class antibody talquetamab show a high clinical response rate in patients with relapsed and refractory multiple myeloma

/ BestPractice Nordic
MyelomatoseEHA21

Flere interessante kliniske data for brentuximab vedotin til patienter med Hodgkin lymfom

/ Martin Hutchings
Hodgkin lymfomEHA21 Play the Video

Improved OS in newly diagnosed multiple myeloma patients not eligible for stem cell transplantation

/ BestPractice Nordic
MyelomatoseEHA21
Mer
Back to top